About Lundbeck UK
Underpinning our vision are three strategic pillars; Deliver excellent results, Deliver value to customers, Be a great place to work. The company’s products are targeted at depression and anxiety, psychotic diseases. Alzheimer’s and Parkinson’s disease.
Lundbeck UK was founded in 1972, and was initially based in Welwyn in Hertfordshire with a staff of four people. The company expanded rapidly, moving initially to larger premises in Luton and then to Milton Keynes. We subsequently moved to larger, modern premises at Caldecotte Lake, Milton Keynes, where we are currently located.
Lundbeck UK markets a number of different pharmaceuticals for the treatment of brain diseases.This includes: Azilect® (Parkinson’s disease), Selincro▼® (alcohol dependency), Brintellix▼® (Depression). Lundbeck UK also co-promotes Abilify Maintena® (schizophrenia) a product distributed by Otsuka UK.
Lundbeck UK currently employs nearly 100 people across the UK. .